PROTEOSTASIS THERAPEUTICS


Proteostasis Therapeutics, Inc.

Proteostasis Therapeutics Announces FDA Grants Breakthrough Therapy Designation for PTI-428 in Cystic Fibrosis

Commentaires

Articles les plus consultés